Glenmark Life Sciences Ltd - 543322 - Closure of Trading Window
As per the "Code of Conduct for Prevention of Insider Trading" and pursuant to the SEBI (Prohibition of Insider Trading) Regulation, 2015, the Company has intimated its "designated persons" regarding the closure of the trading window from September 30, 2023 to October 22, 2023 (both days inclusive) for the purpose of approval of unaudited financial results for second quarter and half year ended September 30, 2023. Glenmark Life Sciences Ltd - 543322 - Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results, Of The Company For The Second Quarter And Half Year Ended 30Th September, 2023.
Glenmark Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2023 ,inter alia, to consider and approve Unaudited Financial Results, of the Company for the second quarter and half year ended 30th September, 2023. Glenmark Life Sciences Ltd - 543322 - Communication Sent To Shareholders Regarding Tax Deduction At Source (TDS) On Dividend Income
The Company has sent a detailed communication today i.e. October 10, 2023, a copy of which is attached herewith. Glenmark Life Sciences Ltd - 543322 - Board Meeting Outcome for Outcome Of The Board Meeting
This is to inform you that the Board of Directors ('Board') of the Company has at its meeting held today i.e. October 09, 2023, inter-alia, declared Interim Equity Dividend for the financial year 2023-24 of Rs. 22.50/- per equity share of Rs. 2 each. As intimated vide our letter dated October 04, 2023, the record date for reckoning the list of shareholders who shall be entitled to receive the said interim dividend shall be Tuesday, October 17, 2023. The interim dividend will be paid to such shareholders on or after October 23, 2023. Glenmark Life Sciences Ltd - 543322 - Draft Letter of Offer
DAM Capital Advisors Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of Glenmark Life Sciences Ltd ("Target Company"). Glenmark Life Sciences Ltd - 543322 - Corporate Action-Board to consider Dividend
The record date for interim dividend, if declared, will be Tuesday, October 17, 2023. Glenmark Life Sciences Ltd - 543322 - Board Meeting Intimation for Board Meeting Intimation For Considering Declaration Of Interim Dividend, If Any.
Glenmark Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/10/2023 ,inter alia, to consider and approve declaration of interim dividend, if any, for the financial year 2023-24. Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Credit Rating
India Ratings and Research rating rational Glenmark Life Sciences Ltd - 543322 - Detailed Public Statement
DAM Capital Advisors Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulations 3(1) and 4 read with Regulations 13(4), 14(3) and 15(2) and other applicable Regulations of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended to the Public Shareholders of Glenmark Life Sciences Ltd ("Target Company"). Glenmark Life Sciences Ltd - 543322 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Proceedings and Scrutinizers Report of 12th Annual General Meeting is attached